Analysis of direct medical care costs of peptic ulcer disease in a Korean tertiary medical center

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 1, 2012, Pages 36-42

  Kang, Jung Mook ^a,b   Seo, Pyoung Ju ^c   Kim, Nayoung ^a,c   Lee, Byoung Hwan ^c   Kwon, Jinweon ^d   Lee, Dong Ho ^a,c   Jung, Hyun Chae ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d National Evidence Based Healthcare Collaborating Agency   (South Korea)

Author keywords

Health care costs; Helicobacter pylori; NSAIDs; Peptic ulcer

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; COST OF ILLNESS; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HEMOSTASIS; HOSPITALIZATION; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HEALTH CARE COSTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER; RECURRENCE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES;

EID: 84055199604     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.639083     Document Type: Article

References (27)

1. Lambert JR, Dunn KL, Eaves ER, Korman MG, Hansky J, Pinkard KJ. Pyloric CLO in the human stomach. Med J Aust 1985;143:174.
2. Kim N, Park YJ, Ahn KJ, Lee GH, Lim BC, Koh YH, et al. The role of Helicobacter pylori and NSAID in patients with benign gastric ulcer. Korean J Med 1998;54:502-13.
3. Ciociola AA, McSorley DJ, Turner K, Sykes D, Palmer JB. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol 1999;94:1834-40. (Pubitemid 29315895)
4. Kim NY, Oh HS, Jung MH, Wee SH, Choi JH, Lee KH. The effect of eradication of Helicobacter pylori upon the duodenal ulcer recurrence-a 24 month follow-up study. Korean J Intern Med 1994;9:72-9.
5. Hawkey CJ. Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 2000;119:521-35. (Pubitemid 30622003)
6. Aalykke C, Lauritsen K. Epidemiology of NSAID-related gastroduodenal mucosal injury. Best Pract Res Clin Gastroenterol 2001;15:705-22. (Pubitemid 32982361)
7. Yim JY, Kim N, Choi SH, Kim YS, Cho KR, Kim SS, et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007;12:333-40. (Pubitemid 47196330)
8. Chung JI, Kim N, Kang KP, Nam TM, Lee JH, Choi CH, et al. Seroprevalence of H. pylori in the health check-up population in 2007. Korean J Helicobacter Upper Gastrointest Res 2008;8:71-5.
9. Kim JI, Kim SG, Kim N, Kim JG, Shin SJ, Kim SW, et al. Changing prevalence of upper gastrointestinal disease in 28 893 Koreans from 1995 to 2005. Eur J Gastroenterol Hepatol 2009;21:787-93.
10. Yu KD, Kim N, Park YS, Hwang JH, Kim JW, Lee DH, et al. Clinical characteristics of elderly Korean patients with peptic ulcer. Korean J Med 2006;71:501-10.
11. Jang HJ, Choi MH, Shin WG, Kim KH, Chung YW, Kim KO, et al. Has peptic ulcer disease changed during the past ten years in Korea? A prospective multi-center study. Dig Dis Sci 2008;53:1527-31. (Pubitemid 351624414)
12. Hung LC, Ching JY, Sung JJ, To KF, Hui AJ, Wong VW, et al. Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study. Gastroenterology 2005;128:1845-50. (Pubitemid 40824696)
13. Wong GL, Wong VW, Chan Y, Ching JY, Au K, Hui AJ, et al. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology 2009;137: 525-31.
14. Sonnenberg A, Everhart JE. Health impact of peptic ulcer in the United States. Am J Gastroenterol 1997;92:614-20. (Pubitemid 27184374)
15. Levin TR, Schmittdiel JA, Kunz K, Henning JM, Henke CJ, Colby CJ, et al. Costs of acid-related disorders to a health maintenance organization. Am J Med 1997;103: 520-8. (Pubitemid 28018655)
16. Agreus L, Borgquist L. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics 2002;20:347-55. (Pubitemid 34569368)
17. Seo PJ, Kim N, Oh JC, Lee BH, Shin CM, Suh S, et al. Comparison of direct medical care costs between erosive reflux disease and non-erosive reflux disease in Korean tertiary medical center. J Neurogastroenterol Motil 2010; 16:291-8.
18. Shin WG, Kim HU, Kim SG, Kim GH, Shim K, Kim JW, et al. Work productivity and activity impairment in gastroesophageal reflux disease in Korean full-time employees: a multicenter study. Dig Liver Dis 2011; in press.
19. Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 1997;24:2-17. (Pubitemid 27051940)
20. Nishikawa K, Sugiyama T, Kato M, Ishizuka J, Komatsu Y, Kagaya H, et al. Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population. Eur J Gastroenterol Hepatol 2000;12:635-40. (Pubitemid 30433538)
21. Chan HL, Wu JC, Chan FK, Choi CL, Ching JY, Lee YT, et al. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients. Gastrointest Endosc 2001;53:438-42. (Pubitemid 33586751)
22. Ruszniewski P. Pharmaco-economic considerations in the long-term management of peptic ulcer disease. Aliment Pharmacol Ther 1993;7(Suppl 2):41-8. (Pubitemid 23198352)
23. Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002;122:1500-11. (Pubitemid 34465190)
24. Jonsson B, Haglund U. Economic burden of NSAIDinduced gastropathy in Sweden. Scand J Gastroenterol 2001;36:775-9. (Pubitemid 32568558)
25. Joish VN, Donaldson G, Stockdale W, Oderda GM, Crawley J, Sasane R, et al. The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database. Curr Med Res Opin 2005;21:535-44.
26. Gillen D, Wirz AA, Neithercut WD, Ardill JE, McColl KE. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole. Gut 1999;44:468-75. (Pubitemid 29169945)
27. Quan C, Talley NJ. Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs. Am J Gastroenterol 2002;97:2950-61. (Pubitemid 35424563)